Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia

Files in this item

This item appears in the following Collection(s)

Attribution 4.0 International Except where otherwise noted, this item's license is described as Attribution 4.0 International

Search Repository


My Account

Statistics